We are live on ! Find out more
PCM

Puissance Capital Management Portfolio holdings

AUM $17.3M
1-Year Est. Return 149.36%
This Fund
S&P 500
This Quarter Est. Return
+63.37%
1 Year Est. Return
+149.36%
3 Year Est. Return
+115.5%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$23.4M
AUM Growth
+$14.9M
Cap. Flow
+$10.8M
Cap. Flow %
46.16%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
BLPH
Bellerophon Therapeutics, Inc.
BLPH
+$8.4M
2
SCYX icon
SCYNEXIS
SCYX
+$2.57M

Top Sells

Rank Stock Value
1
KDMN
Kadmon Holdings, Inc.
KDMN
+$126K
2
TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
+$31K

Sector Composition

Rank Sector Weight
1 Technology 27.77%
2 Healthcare 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLPH
1
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$14.5M 61.82%
1,153,846
+600,596
+109% +$8.4M
CHRN
2
ChronoScale Holdings
CHRN
$2.69B
$6.5M 27.77%
51,627
– –
SCYX icon
3
SCYNEXIS
SCYX
$37.4M
$2.34M 9.97%
38,893
+37,817
+3,515% +$2.57M
CRVS icon
4
Corvus Pharmaceuticals
CRVS
$1.1B
$103K 0.44%
38,010
– –
TCON
5
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
– –
-905
Closed -$31K
KDMN
6
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-30,000
Closed -$126K

Similar funds

FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
IAM
ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return
FP
FFL Partners San Francisco, California $16.1M AUM 46.91% 1-Year Est. Return
AF
AMG Funds Stamford, Connecticut $20M AUM 3.75% 1-Year Est. Return
TCS
Texas Children's Houston, Texas $20.5M AUM 51.2% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
PCM
Proxima Capital Management New York $21M AUM 3.49% 1-Year Est. Return
NC
Numen Capital London, United Kingdom $13.5M AUM 47.6% 1-Year Est. Return

Puissance Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Puissance Capital Management held 6 positions worth $23.4M, up 174% from $8.56M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Puissance Capital Management deployed $10.8M of net new capital in Q2 2020, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare.

On the sell side, the most notable exit was Kadmon Holdings, Inc., an estimated $126K sold.

  • Puissance Capital Management added most to Bellerophon Therapeutics, Inc. in Q2 2020, an estimated $8.4M increase.
  • Puissance Capital Management fully exited Kadmon Holdings, Inc. in Q2 2020, selling an estimated $126K.
  • Puissance Capital Management's ten largest holdings make up 100% of its $23.4M portfolio in Q2 2020.
  • Puissance Capital Management opened 0 new positions and closed 2 in Q2 2020.
  • Puissance Capital Management's portfolio value rose 174% quarter-over-quarter to $23.4M.

Based on Puissance Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.